167 related articles for article (PubMed ID: 9892174)
1. Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture.
Freedman DA; Levine AJ
Cancer Res; 1999 Jan; 59(1):1-7. PubMed ID: 9892174
[No Abstract] [Full Text] [Related]
2. The tumorigenic potential and cell growth characteristics of p53-deficient cells are equivalent in the presence or absence of Mdm2.
Jones SN; Sands AT; Hancock AR; Vogel H; Donehower LA; Linke SP; Wahl GM; Bradley A
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14106-11. PubMed ID: 8943068
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis.
Jones SN; Hancock AR; Vogel H; Donehower LA; Bradley A
Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15608-12. PubMed ID: 9861017
[TBL] [Abstract][Full Text] [Related]
4. Mdm2: keeping p53 under control.
Piette J; Neel H; Maréchal V
Oncogene; 1997 Aug; 15(9):1001-10. PubMed ID: 9285554
[TBL] [Abstract][Full Text] [Related]
5. MDM2 oncogene as a novel target for human cancer therapy.
Zhang ; Wang H
Curr Pharm Des; 2000 Mar; 6(4):393-416. PubMed ID: 10788589
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
[TBL] [Abstract][Full Text] [Related]
7. Regulating the p53 pathway: in vitro hypotheses, in vivo veritas.
Toledo F; Wahl GM
Nat Rev Cancer; 2006 Dec; 6(12):909-23. PubMed ID: 17128209
[TBL] [Abstract][Full Text] [Related]
8. Re: Role of the heat shock response and molecular chaperones in oncogenesis and cell death.
Blagosklonny MV
J Natl Cancer Inst; 2001 Feb; 93(3):239-40. PubMed ID: 11158196
[No Abstract] [Full Text] [Related]
9. Control of p53 ubiquitination and nuclear export by MDM2 and ARF.
Zhang Y; Xiong Y
Cell Growth Differ; 2001 Apr; 12(4):175-86. PubMed ID: 11331246
[TBL] [Abstract][Full Text] [Related]
10. Exploiting the p53 pathway for cancer diagnosis and therapy.
Lane DP
Br J Cancer; 1999 Jul; 80 Suppl 1():1-5. PubMed ID: 10466753
[No Abstract] [Full Text] [Related]
11. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans.
Bond GL; Hu W; Bond EE; Robins H; Lutzker SG; Arva NC; Bargonetti J; Bartel F; Taubert H; Wuerl P; Onel K; Yip L; Hwang SJ; Strong LC; Lozano G; Levine AJ
Cell; 2004 Nov; 119(5):591-602. PubMed ID: 15550242
[TBL] [Abstract][Full Text] [Related]
12. Mdm2 ligase dead mutants did not act in a dominant negative manner to re-activate p53, but promoted tumor cell growth.
Swaroop M; Sun Y
Anticancer Res; 2003; 23(4):3167-74. PubMed ID: 12926050
[TBL] [Abstract][Full Text] [Related]
13. Exogenous wt-p53 protein is active in transformed cells but not in their non-transformed counterparts: implications for cancer gene therapy without tumor targeting.
D'Orazi G; Marchetti A; Crescenzi M; Coen S; Sacchi A; Soddu S
J Gene Med; 2000; 2(1):11-21. PubMed ID: 10765501
[TBL] [Abstract][Full Text] [Related]
14. A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin J; Jin X; Page C; Sondak VK; Jiang G; Reynolds RK
Cancer Res; 2000 Oct; 60(20):5895-901. PubMed ID: 11059788
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of MDM2 in acute childhood lymphoblastic leukemia.
Gustafsson B; Stål O; Gustafsson B
Pediatr Hematol Oncol; 1998; 15(6):519-26. PubMed ID: 9842645
[TBL] [Abstract][Full Text] [Related]
16. P53 and MDM2 co-expression in tobacco and betel chewing-associated oral squamous cell carcinomas.
Shwe M; Chiguchi G; Yamada S; Nakajima T; Maung KK; Takagi M; Amagasa T; Tsuchida N
J Med Dent Sci; 2001 Dec; 48(4):113-9. PubMed ID: 12160248
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells.
Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH
Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889
[TBL] [Abstract][Full Text] [Related]
18. Higher-grade transformation of follicular lymphoma -- a continuous enigma.
Lossos IS
Leukemia; 2005 Aug; 19(8):1331-3. PubMed ID: 15902286
[No Abstract] [Full Text] [Related]
19. MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.
Dubs-Poterszman MC; Tocque B; Wasylyk B
Oncogene; 1995 Dec; 11(11):2445-9. PubMed ID: 8570197
[TBL] [Abstract][Full Text] [Related]
20. p53 gene family p51(p63)-encoded, secondary transactivator p51B(TAp63alpha) occurs without forming an immunoprecipitable complex with MDM2, but responds to genotoxic stress by accumulation.
Okada Y; Osada M; Kurata S; Sato S; Aisaki K; Kageyama Y; Kihara K; Ikawa Y; Katoh I
Exp Cell Res; 2002 Jun; 276(2):194-200. PubMed ID: 12027449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
